These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
472 related items for PubMed ID: 31210057
1. Peptide PD29 treats bleomycin-induced pulmonary fibrosis by inhibiting the TGF-β/smad signaling pathway. Sun Q, Hu J, Yu P, Zhu Z, Yu R, Ge C, Li C, Wu G, Lin B, Liu G, Liu M, Bian H, Xu H, Jia S. Exp Lung Res; 2019; 45(5-6):123-134. PubMed ID: 31210057 [Abstract] [Full Text] [Related]
2. Paeoniflorin suppresses TGF-β mediated epithelial-mesenchymal transition in pulmonary fibrosis through a Smad-dependent pathway. Ji Y, Dou YN, Zhao QW, Zhang JZ, Yang Y, Wang T, Xia YF, Dai Y, Wei ZF. Acta Pharmacol Sin; 2016 Jun; 37(6):794-804. PubMed ID: 27133302 [Abstract] [Full Text] [Related]
3. Salidroside protects against bleomycin-induced pulmonary fibrosis: activation of Nrf2-antioxidant signaling, and inhibition of NF-κB and TGF-β1/Smad-2/-3 pathways. Tang H, Gao L, Mao J, He H, Liu J, Cai X, Lin H, Wu T. Cell Stress Chaperones; 2016 Mar; 21(2):239-49. PubMed ID: 26577463 [Abstract] [Full Text] [Related]
4. Tanshinone IIA ameliorates bleomycin-induced pulmonary fibrosis and inhibits transforming growth factor-beta-β-dependent epithelial to mesenchymal transition. Tang H, He H, Ji H, Gao L, Mao J, Liu J, Lin H, Wu T. J Surg Res; 2015 Jul; 197(1):167-75. PubMed ID: 25911951 [Abstract] [Full Text] [Related]
5. Emodin ameliorates bleomycin-induced pulmonary fibrosis in rats by suppressing epithelial-mesenchymal transition and fibroblast activation. Guan R, Wang X, Zhao X, Song N, Zhu J, Wang J, Wang J, Xia C, Chen Y, Zhu D, Shen L. Sci Rep; 2016 Oct 24; 6():35696. PubMed ID: 27774992 [Abstract] [Full Text] [Related]
6. Myricetin ameliorates bleomycin-induced pulmonary fibrosis in mice by inhibiting TGF-β signaling via targeting HSP90β. Li X, Yu H, Liang L, Bi Z, Wang Y, Gao S, Wang M, Li H, Miao Y, Deng R, Ma L, Luan J, Li S, Liu M, Lin J, Zhou H, Yang C. Biochem Pharmacol; 2020 Aug 24; 178():114097. PubMed ID: 32535102 [Abstract] [Full Text] [Related]
7. Synergistic protection of Schizandrin B and Glycyrrhizic acid against bleomycin-induced pulmonary fibrosis by inhibiting TGF-β1/Smad2 pathways and overexpression of NOX4. Zhang D, Liu B, Cao B, Wei F, Yu X, Li GF, Chen H, Wei LQ, Wang PL. Int Immunopharmacol; 2017 Jul 24; 48():67-75. PubMed ID: 28476015 [Abstract] [Full Text] [Related]
8. Andrographolide ameliorates bleomycin-induced pulmonary fibrosis by suppressing cell proliferation and myofibroblast differentiation of fibroblasts via the TGF-β1-mediated Smad-dependent and -independent pathways. Li J, Feng M, Sun R, Li Z, Hu L, Peng G, Xu X, Wang W, Cui F, Yue W, He J, Liu J. Toxicol Lett; 2020 Mar 15; 321():103-113. PubMed ID: 31706003 [Abstract] [Full Text] [Related]
9. Oxymatrine attenuates bleomycin-induced pulmonary fibrosis in mice via the inhibition of inducible nitric oxide synthase expression and the TGF-β/Smad signaling pathway. Liu L, Lu W, Ma Z, Li Z. Int J Mol Med; 2012 May 15; 29(5):815-22. PubMed ID: 22367596 [Abstract] [Full Text] [Related]
10. Protective role of rhapontin in experimental pulmonary fibrosis in vitro and in vivo. Tao L, Cao J, Wei W, Xie H, Zhang M, Zhang C. Int Immunopharmacol; 2017 Jun 15; 47():38-46. PubMed ID: 28364627 [Abstract] [Full Text] [Related]
13. Regulation of Transforming Growth Factor-β/Smad-mediated Epithelial-Mesenchymal Transition by Celastrol Provides Protection against Bleomycin-induced Pulmonary Fibrosis. Divya T, Velavan B, Sudhandiran G. Basic Clin Pharmacol Toxicol; 2018 Aug 15; 123(2):122-129. PubMed ID: 29394529 [Abstract] [Full Text] [Related]
14. Cryptotanshinone protects against pulmonary fibrosis through inhibiting Smad and STAT3 signaling pathways. Zhang Y, Lu W, Zhang X, Lu J, Xu S, Chen S, Zhong Z, Zhou T, Wang Q, Chen J, Liu P. Pharmacol Res; 2019 Sep 15; 147():104307. PubMed ID: 31181334 [Abstract] [Full Text] [Related]
15. Sunitinib, a Small-Molecule Kinase Inhibitor, Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice. Huang X, Wang W, Yuan H, Sun J, Li L, Wu X, Luo J, Gu Y. Tohoku J Exp Med; 2016 Aug 15; 239(4):251-61. PubMed ID: 27439438 [Abstract] [Full Text] [Related]
16. Tanshinone IIA attenuates silica-induced pulmonary fibrosis via Nrf2-mediated inhibition of EMT and TGF-β1/Smad signaling. Feng F, Cheng P, Xu S, Li N, Wang H, Zhang Y, Wang W. Chem Biol Interact; 2020 Mar 01; 319():109024. PubMed ID: 32097614 [Abstract] [Full Text] [Related]
17. Ginkgo biloba Extract 50 (GBE50) Exerts Antifibrotic and Antioxidant Effects on Pulmonary Fibrosis in Mice by Regulating Nrf2 and TGF-β1/Smad Pathways. Liang W, Yang H, Pan L, Wei S, Li Z, Zhang P, Li R, Wu Y, Liu M, Liu X. Appl Biochem Biotechnol; 2024 Aug 01; 196(8):4807-4822. PubMed ID: 37971580 [Abstract] [Full Text] [Related]
18. Protective effects of GHK-Cu in bleomycin-induced pulmonary fibrosis via anti-oxidative stress and anti-inflammation pathways. Ma WH, Li M, Ma HF, Li W, Liu L, Yin Y, Zhou XM, Hou G. Life Sci; 2020 Jan 15; 241():117139. PubMed ID: 31809714 [Abstract] [Full Text] [Related]
19. Emodin Attenuates Bleomycin-Induced Pulmonary Fibrosis via Anti-Inflammatory and Anti-Oxidative Activities in Rats. Tian SL, Yang Y, Liu XL, Xu QB. Med Sci Monit; 2018 Jan 01; 24():1-10. PubMed ID: 29290631 [Abstract] [Full Text] [Related]
20. Naja naja atra venom ameliorates pulmonary fibrosis by inhibiting inflammatory response and oxidative stress. Cui K, Kou JQ, Gu JH, Han R, Wang G, Zhen X, Qin ZH. BMC Complement Altern Med; 2014 Dec 02; 14():461. PubMed ID: 25465226 [Abstract] [Full Text] [Related] Page: [Next] [New Search]